Canadian Pharmacy Blog

Oral antibiotic omnicef (cefdinir) is indicated for pediatric patients (ages six months to 12 years) in the form of suspension to treat from mild to moderate infections: acute bacterial otitis media, Haemophilus influenzae (including beta-lactamase-producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only) and Moraxella catarrhalis (including beta-lactamase-producing strains); and pharyngitis/tonsillitis [...]